Allorion Therapeutics
Manufacturing · Massachusetts, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
22 Strathmore Rd, Natick, Massachusetts,...Phone Number
(781) 496-9957Website
www.alloriontx.comRevenue
$14.5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Allorion Therapeutics
Allorion Therapeutics is a company focusing on next-generation precision medicine for oncology and autoimmune disease. Allorion Therapeutics is headquartered in Natick, Massachusetts.Explore more
Allorion Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Allorion Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Allorion Therapeutics recently announced quarterly report
Click to see if Allorion Therapeutics had a recent Job posting/layoffs
Allorion Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Allorion Therapeutics launches new products
Funding: Get notified immidiatlly once Allorion Therapeutics has new funding data
Check if Allorion Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Check out if Allorion Therapeutics is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Allorion Therapeutics
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at Allorion Therapeutics
Find more new buyers
Compare Similar Companies to Allorion Therapeutics
Compare insights from companies similar to Allorion Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$13.5M
51-200
Private
-
2019
Kristin PolsenskiChief of Staff to CEO & Vice President, Portfolio, Program & Alliance Management
Company Profile Activity
Activity Insights
Allorion Therapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Allorion Therapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Allorion Therapeutics.
Allorion Therapeutics financials insights
Gather financial insights about Allorion Therapeutics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Series A
$40M
2023
Series B
$50M
Allorion Therapeutics Tech Stack
Most Recent Scoops
New Hire
Executive Move
Funding
Open Position
Open Position
Open Position
Allorion Therapeutics News & Media
Allorion Therapeutics Announces Exclusive Option and Global License Agreement for Novel Preclinical-Stage EGFR L858R Allosteric Inhibitor Program with AstraZeneca
NATICK, Mass., Jan. 2, 2024 /PRNewswire/ -- Allorion Therapeutics ("Allorion"), a US and China-based biotechnology company that focuses on the discovery of new small molecule drugs for treating cancer and autoimmune diseases, has entered into an exclusive option and global license agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) to develop and commercialize a novel epidermal growth factor receptor (EGFR) L858R mutated allosteric inhibitor, as a potential new treatment for advanced EGFR-mutant noALLORION THERAPEUTICS ANNOUNCES FIRST PATIENT DOSED IN PHASE 1/2 STUDY OF ARTS-021, A POTENTIAL BEST IN CLASS CDK2 INHIBITOR, FOR ADVANCED OR METASTATIC SOLID TUMORS
NATICK, Mass., Oct. 11, 2023 /PRNewswire/ -- Allorion Therapeutics (Allorion), a clinical-stage biotechnology company dedicated to the discovery and development of next-generation targeted drugs for cancer and autoimmune diseases, announced today the dosing of its first patient in the...Crystal Pharmatech Recognized as "Best Partner" by Allorion Therapeutics for Excellent Services
SUZHOU, China, July 7, 2023 /PRNewswire/ -- Crystal Pharmatech, a leading pharmaceutical technology company, has received dual recognition from its esteemed partner, Allorion Therapeutics (Boston, US / Guangzhou, China) who is an innovation-based biotech company aiming at developing novel...Allorion Therapeutics, a next-generation precision medicine company focusing on oncology and autoimmune diseases, raises $50 million Series B financing
BOSTON, March 9, 2023 /PRNewswire/ -- Allorion Therapeutics ("Allorion"), a biotech company focusing on next-generation precision medicine for oncology and autoimmune diseases, announces the completion of a $50 million Series B financing round, co-led by INCE Capital and Qiming Venture...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Allorion Therapeutics
Sign Up For FreeTo access detailed company insights
Allorion Therapeutics is a company focusing on next-generation precision medicine for oncology and autoimmune disease. Allorion Therapeutics is headquartered in Natick, Massachusetts.... Read More
